170 related articles for article (PubMed ID: 12553056)
1. Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.
Cavaletti G; Petruccioli MG; Marmiroli P; Rigolio R; Galbiati S; Zoia C; Ferrarese C; Tagliabue E; Dolci C; Bayssas M; Griffon Etienne G; Tredici G
Anticancer Res; 2002; 22(6C):4199-204. PubMed ID: 12553056
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss.
Jamieson SM; Liu J; Connor B; McKeage MJ
Cancer Chemother Pharmacol; 2005 Oct; 56(4):391-9. PubMed ID: 15887017
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.
Cavaletti G; Gilardini A; Canta A; Rigamonti L; Rodriguez-Menendez V; Ceresa C; Marmiroli P; Bossi M; Oggioni N; D'Incalci M; De Coster R
Exp Neurol; 2007 Mar; 204(1):317-25. PubMed ID: 17214983
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats.
Tredici G; Braga M; Nicolini G; Miloso M; Marmiroli P; Schenone A; Nobbio L; Frattola L; Cavaletti G
Exp Neurol; 1999 Oct; 159(2):551-8. PubMed ID: 10506527
[TBL] [Abstract][Full Text] [Related]
5. Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.
Carozzi VA; Canta A; Oggioni N; Sala B; Chiorazzi A; Meregalli C; Bossi M; Marmiroli P; Cavaletti G
Exp Neurol; 2010 Dec; 226(2):301-9. PubMed ID: 20832406
[TBL] [Abstract][Full Text] [Related]
6. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol.
Cavaletti G; Tredici G; Braga M; Tazzari S
Exp Neurol; 1995 May; 133(1):64-72. PubMed ID: 7601264
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.
Meijer C; de Vries EG; Marmiroli P; Tredici G; Frattola L; Cavaletti G
Neurotoxicology; 1999 Dec; 20(6):883-7. PubMed ID: 10693969
[TBL] [Abstract][Full Text] [Related]
8. Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs.
Screnci D; McKeage MJ; Galettis P; Hambley TW; Palmer BD; Baguley BC
Br J Cancer; 2000 Feb; 82(4):966-72. PubMed ID: 10732773
[TBL] [Abstract][Full Text] [Related]
9. Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice.
Bruna J; Udina E; Alé A; Vilches JJ; Vynckier A; Monbaliu J; Silverman L; Navarro X
Exp Neurol; 2010 Jun; 223(2):599-608. PubMed ID: 20188093
[TBL] [Abstract][Full Text] [Related]
10. Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.
De Santis S; Pace A; Bove L; Cognetti F; Properzi F; Fiore M; Triaca V; Savarese A; Simone MD; Jandolo B; Manzione L; Aloe L
Clin Cancer Res; 2000 Jan; 6(1):90-5. PubMed ID: 10656436
[TBL] [Abstract][Full Text] [Related]
11. Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model.
Holmes J; Stanko J; Varchenko M; Ding H; Madden VJ; Bagnell CR; Wyrick SD; Chaney SG
Toxicol Sci; 1998 Dec; 46(2):342-51. PubMed ID: 10048138
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats.
Meregalli C; Canta A; Carozzi VA; Chiorazzi A; Oggioni N; Gilardini A; Ceresa C; Avezza F; Crippa L; Marmiroli P; Cavaletti G
Eur J Pain; 2010 Apr; 14(4):343-50. PubMed ID: 19695912
[TBL] [Abstract][Full Text] [Related]
13. Nucleolar enlargement, nuclear eccentricity and altered cell body immunostaining characteristics of large-sized sensory neurons following treatment of rats with paclitaxel.
Jamieson SM; Liu JJ; Connor B; Dragunow M; McKeage MJ
Neurotoxicology; 2007 Nov; 28(6):1092-8. PubMed ID: 17686523
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy.
Gao WQ; Dybdal N; Shinsky N; Murnane A; Schmelzer C; Siegel M; Keller G; Hefti F; Phillips HS; Winslow JW
Ann Neurol; 1995 Jul; 38(1):30-7. PubMed ID: 7611721
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol prevents functional deficits in peripheral nerve mitochondria of rats with oxaliplatin-evoked painful peripheral neuropathy.
Areti A; Komirishetty P; Kumar A
Toxicol Appl Pharmacol; 2017 May; 322():97-103. PubMed ID: 28286117
[TBL] [Abstract][Full Text] [Related]
16. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.
Cavaletti G; Tredici G; Petruccioli MG; Dondè E; Tredici P; Marmiroli P; Minoia C; Ronchi A; Bayssas M; Etienne GG
Eur J Cancer; 2001 Dec; 37(18):2457-63. PubMed ID: 11720843
[TBL] [Abstract][Full Text] [Related]
17. Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat.
Cavaletti G; Cavalletti E; Montaguti P; Oggioni N; De Negri O; Tredici G
Neurotoxicology; 1997; 18(1):137-45. PubMed ID: 9215996
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
19. Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity.
Liu JJ; Jamieson SM; Subramaniam J; Ip V; Jong NN; Mercer JF; McKeage MJ
Cancer Chemother Pharmacol; 2009 Sep; 64(4):847-56. PubMed ID: 19466412
[TBL] [Abstract][Full Text] [Related]
20. Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity.
Carozzi V; Chiorazzi A; Canta A; Oggioni N; Gilardini A; Rodriguez-Menendez V; Avezza F; Crippa L; Ceresa C; Nicolini G; Bossi M; Cavaletti G
Eur J Cancer; 2009 Mar; 45(4):656-65. PubMed ID: 19091544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
